Aquatic Capital Management’s Sunrun RUN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.88M Buy
285,857
+135,836
+91% +$2.26M 0.11% 242
2025
Q4
$2.76M Buy
150,021
+104,121
+227% +$2M 0.08% 302
2025
Q3
$794K Buy
+45,900
New +$614K 0.01% 743
2025
Q1
Sell
-524,949
Closed -$4.86M 1583
2024
Q4
$4.86M Buy
524,949
+314,449
+149% +$3.91M 0.13% 203
2024
Q3
$3.8M Buy
210,500
+171,500
+440% +$3.05M 0.1% 236
2024
Q2
$463K Sell
39,000
-573,600
-94% -$7.03M 0.02% 554
2024
Q1
$8.07M Buy
+612,600
New +$8.42M 0.26% 97
2023
Q2
Sell
-1,200
Closed -$24K 1699
2023
Q1
$24K Sell
1,200
-48,500
-98% -$1.13M ﹤0.01% 1024
2022
Q4
$1.19M Buy
49,700
+23,800
+92% +$635K 0.09% 280
2022
Q3
$715K Buy
+25,900
New +$806K 0.07% 332
2022
Q2
Sell
-2,000
Closed -$61K 1530
2022
Q1
$61K Buy
2,000
+1,900
+1,900% +$53K 0.09% 245
2021
Q4
$3K Buy
+100
New +$4.68K 0.01% 1016

Other funds holding RUN

Aquatic Capital Management's RUN Position: Q1 2026 in Review

Aquatic Capital Management increased its Sunrun (RUN) stake by 91% in Q1 2026, buying an estimated $2.26M and bringing the position to 285,857 shares worth $3.88M. The position accounts for 0.11% of the portfolio, ranked #242.

Aquatic Capital Management first reported a position in RUN in Q4 2021 and has held it in 12 quarters since. The position peaked at $8.07M in Q1 2024. 397 funds tracked by Wall St. Rank hold RUN as of Q1 2026.

  • Aquatic Capital Management held 285,857 shares of Sunrun worth $3.88M as of Q1 2026.
  • Aquatic Capital Management bought 135,836 Sunrun shares in Q1 2026, an estimated $2.26M.
  • Sunrun made up 0.11% of Aquatic Capital Management's portfolio in Q1 2026, its #242 holding.
  • Aquatic Capital Management first reported a position in Sunrun in Q4 2021 and has held it in 12 quarters since.
  • Aquatic Capital Management's Sunrun position peaked at $8.07M in Q1 2024.
  • 397 funds tracked by Wall St. Rank held Sunrun as of Q1 2026.

Based on Aquatic Capital Management's 13F filing for Q1 2026, filed 15 May 2026.